Christopher Austin is global head of Orrick’s Capital Markets practice and co-lead of Orrick’s global Fintech team, helping many industry participants navigate this complex and evolving sector. He focuses on capital markets and corporate law, with extensive experience in public offerings, public company representations and securities law compliance.

Chris counsels technology companies of all sizes and stages of development, including advising on formation, venture financings, mergers and acquisitions, initial public offerings, corporate governance, and intellectual property issues. He is a recognized leader in capital markets work for investment banks, including BAML,  Goldman Sachs, J.P. Morgan and Morgan Stanley, in connection with initial public offerings and follow-on offerings of technology and life sciences companies.

  • His recent transactions include the initial public offerings of Arcadia BioScience, Benefitfocus, Eloqua, On Deck, Ooma, Paylocity and Rapid7, multiple public offerings of Intercept Pharmaceuticals stock, and venture capital financings and secondary stock transactions for Betterment and SoFi.

    Prior to joining Orrick, Chris was a partner at Goodwin Procter for four years, and a partner at Ropes & Gray for 16 years, including three years in its San Francisco office.

  • Chris's recent engagements include:

    • Ooma, Inc., a provider of voice over IP communications solutions, in its $65 million initial public offering
    • Morgan Stanley and Barclays, as underwriters counsel, in the $130 million initial public offering of Rapid7, Inc.
    • Social Finance, Inc., in its $200 million venture capital financing
    • Morgan Stanley, BofA Merrill Lynch, J.P. Morgan and Deutsche Bank, as underwriters counsel, in the $230 million initial public offering of OnDeck Capital, Inc., an online alternative finance company for small businesses.
    • Arcadia BioSciences, a developer of novel agricultural seed traits, in its $66 million initial public offering
    • Coatue, in its $500 million investment in Liberty Media to support Charter Communications’ acquisition of Time Warner
    • BofA Merrill Lynch, Citi Group, BMO Capital Markets, Needham & Company, Wedbush PacGrow Life Sciences, ThinkEquity LLC, Deutsche Bank Securities and Goldman, Sachs & Company, as underwriter’s counsel, in its IPO and multiple follow-on equity offerings of Intercept Pharmaceuticals, Inc., a development stage biopharmaceutical company, with an aggregate value of more than $665 million.
    • Deutsche Bank Securities, BofA Merrill Lynch, William Blair & Company, JMP Securities, Raymond James & Associates and Needham & Company, as underwriter’s counsel, in the $137.8 million NASDAQ initial public offering and the $121 million follow-on offering of Paylocity, Inc., a provider of cloud-based payroll and human capital management (HCM) software solutions.
    • Goldman, Sachs & Company, Deutsche Bank Securities, Jefferies, Canaccord Genuity, Piper Jaffray and Raymond James, as underwriter’s counsel, in the $130.8 million NASDAQ initial public offering and $109.9 million follow-on offering of Benefitfocus, Inc., a provider of cloud-based benefits software solutions for consumers, employers, insurance carriers, and brokers.
    • Eloqua, Inc., a provider of on-demand revenue performance management software solutions, in its $105.8 million initial public offering on NASDAQ.
    • BofA Merrill Lynch, as underwriter’s counsel, in the $70 million NASDAQ initial public offering of e2open, Inc., a provider of cloud-based, on-demand software solutions for supply chain management.
    • Goldman, Sachs & Company and Deutsche Bank Securities, as underwriter’s counsel, in the $88 million NYSE initial public offering of Demandware, Inc., a provider of cloud-based digital commerce solutions.

Insights

News